I
Integra LifeSciences Holdings Corporation (IART)
NMS – Real Time Price. Currency in USD
13.77
-0.20 (-1.43%)
At close: May 12, 2026, 4:00 PM EDT
15.16
+1.39 (10.09%)
After-hours: May 12, 2026, 7:57 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
13.77
-0.20 (-1.43%)
At close: May 12, 2026, 4:00 PM EDT
15.16
+1.39 (10.09%)
After-hours: May 12, 2026, 7:57 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.38 | 3.40 | 10 | |
| Quick ratio | 1.95 | 2.52 | 9.0 | |
| Debt to Equity | 1.96 | 1.11 | 3.0 | |
| Debt to Assets | 0.57 | 1.58 | 4.0 | |
| Interest coverage | 1.49 | 4.33 | 4.0 | |
| Weighted average score | 6.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 1.56B | 1.54B | 1.61B | 1.64B | 1.64B |
| Gross Profit | 928M | 894M | 899M | 862M | 907M |
| Operating Income | 273M | 221M | 183M | 182M | 168M |
| Net Income | 181M | 68M | -7M | -516M | -496M |
| EBITDA | 391M | 344M | 323M | 334M | 320M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 0.45 | 7.06 | 3.5 |
| Next quarter | 3.99 | 5.38 | 4.5 |
| Current year | 2.51 | 9.22 | 5.0 |
| Next year | 3.32 | 7.38 | 4.5 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -9.88 | -170.94 | -34.93 | 6.54 | 2.0 |
| Y/Y | 2.42 | 81.75 | 31.71 | 87.44 | 8.3 |
| 3y average | 1.66 | -2503.46 | -12.66 | -119.09 | 1.5 |
| 5y average | 3.68 | -1495.46 | -0.5 | -62.59 | 1.8 |
| Weighted average score | 3.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $2.0B significantly exceeds cash reserves ($236.8M), raising financial stability concerns
Total current assets $1.2B exceed Total current liabilities $346.8M, highlighting excellent liquidity
Debt-to-equity ratio (2.0) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (1.5x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$5.0M limits the company's ability to reinvest or pay down debt